Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
03/2005
03/02/2005EP1509524A1 Xanthine phosphodiesterase v inhibitor polymorphs
03/02/2005EP1509520A1 Use of benzo(c)quinolizinium derivatives for the treatment of diseases that are linked to smooth muscle cell constriction
03/02/2005EP1509506A1 Pyridazine derivatives
03/02/2005EP1509489A1 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof
03/02/2005EP1509268A1 Drug delivery assembly
03/02/2005EP1509251A2 Nucleic acids, polypeptides, and methods for modulating apoptosis
03/02/2005EP1509223A1 Hepatoprotective activity of 10-o-p-hydroxybenzoyiaucubin
03/02/2005EP1509199A1 Dry powder inhalant composition
03/02/2005EP1509188A2 Compounds active at the glucocorticoid receptor ii
03/02/2005EP1384476B1 Azolylcarbynol derivatives of aryl (or heteroaryl) for the treatment of respiratory diseases
03/02/2005EP1345591B1 Pharmaceutical aerosol formulation
03/02/2005EP1244649B1 Cyclic amp-specific phosphodiesterase inhibitors
03/02/2005EP1238979B1 Fused heterotricyclic compounds, process for preparing the compounds and drugs containing the same
03/02/2005EP1042279B1 Substituted beta-alanines
03/02/2005EP1030667B1 Use of mirtazapine for the manufacture of a medicament for treating sleep apneas
03/02/2005EP1014976B1 Novel substituted imidazole compounds
03/02/2005EP0876347B1 Quinoline derivatives
03/02/2005EP0824530B1 Aryl glycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds
03/02/2005EP0799311B1 Human chemokine beta-9
03/02/2005CN1589268A Substituted benzopyrans compounds as selective estrogen receptor-beta agonists
03/02/2005CN1589261A Piperidine derivatives and their use as modulators of chemokine receptor activity (especially CCR5)
03/02/2005CN1589260A Heterocyclic compounds and methods of use thereof
03/02/2005CN1589151A Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof
03/02/2005CN1589146A Benzothiazole derivatives as adenosine receptor ligands
03/02/2005CN1589136A Pharmaceutical and cosmetic compositions containing oxy group-bearing aromatic aldehydes
03/02/2005CN1586605A Use of compound red sage rot in preparing medicine for treating laryngopharngitis and tonsillitis
03/02/2005CN1586597A Ginseng oral disintegration tablet and its preparing process
03/02/2005CN1586596A American ginseng and its extract oral disintegration tablet and its preparing process
03/02/2005CN1586584A Sinusitis capsule and its preparing method
03/02/2005CN1586581A Lozenge for sobering and clearing smoke
03/02/2005CN1586569A Oral health liquid
03/02/2005CN1586552A External plaster for treating baby heat cough and preparing method
03/02/2005CN1586543A Children health pectoral mixture for treating child wind and heat caused by exopathogen and its preparing method
03/02/2005CN1586541A External use medicine for preventing respiratory infectious disease and its preparing method
03/02/2005CN1586532A Liushen oral disintegration tablet and its preparing method
03/02/2005CN1586530A Oral disintegration tablet for laryngopathy and its preparing method
03/02/2005CN1586514A Recipe of medicine for treating rhinitis
03/02/2005CN1586486A Cefpodoxime proxetil soft capsule preparation and its preparing method
03/02/2005CN1586484A Dipyridamole soft capsule preparation and its preparing method
03/02/2005CN1586481A Procaterol dripping pill and its preparing method
03/02/2005CN1586477A Amoxicillin-ambroxol dripping pill
03/02/2005CN1586466A Compound dispersion tablet of acetaminophen and benadryl and its preparing method
03/02/2005CN1586464A Compound ambroxol dripping pill
03/02/2005CN1191362C Streptococcus antigens
03/02/2005CN1191266C Compositions for treating inflammatory response
03/02/2005CN1191246C Indolylpiperidine derivatives as antihistaminic and antiallergic agents
03/02/2005CN1191063C Antagonists for treatment of CD11/CD18 adhesion receptor mediated disorders
03/01/2005US6861532 Synthesis of 2-alkylcysteine
03/01/2005US6861449 Method of treating neutrophil-related diseases with topical anesthetics
03/01/2005US6861429 2,3-diaryl-pyrazolo[1,5-b]pyridazines derivatives, their preparation and their use as cyclooxygenase 2 (COX-2) inhibitors
03/01/2005US6861418 Modulating protein kinase signal transduction; anticancer agents
03/01/2005US6861417 Such as 2-(4-fluorophenyl)-3-(pyridin-4-yl)pyrazine for treating cytokine mediated diseases such as psoriatic arthritis
03/01/2005US6861406 Use of peptides or small molecules in treatment of disease, in high-throughput screening, in use of metal-binding peptides derived from sequences present in CD74-homology domain of insulin-like growth factor
02/2005
02/24/2005WO2005016928A1 Imidazopyridine derivatives
02/24/2005WO2005016514A2 Combinatorial synthesis on support
02/24/2005WO2005016351A1 Novel use of cannabinoid receptor agonist
02/24/2005WO2004112708A3 Regulation of matrix metalloproteinase gene expression using specific and selective electrical and electromagnetic signals
02/24/2005WO2004087195A3 Therapeutic use of modulators of notch and/or kruppel-like factors
02/24/2005WO2004074438A3 Ccr8 antagonists
02/24/2005WO2003018758A3 Reagents and methods for smooth muscle therapies
02/24/2005US20050043536 Sulfonamides
02/24/2005US20050043516 TACI antibodies and uses thereof
02/24/2005US20050043399 Dimeric compounds and their use as anti-viral agents
02/24/2005US20050043394 For prophylaxis and therapy of diabetes mellitus, inflammation, cancer, necrosis, gastric ulcers, neurodegenerative diseases, neuropathic diseases, neuropathic pain and polyneuropathy; free fatty acids and/or fatty acid esters and uridine, deoxyuridine, uridine monophosphate, deoxyuridine monophosphate
02/24/2005US20050043386 2-amino-2-(ethyl or methyl)-4-{5-substituted pyrrol-2-yl}butan-1-ols, phosphates and phosphonates; antiarthritic agents; psoriasis; immunosuppressants
02/24/2005US20050043349 1-Alkyl-1-azoniabicyclo' 2.2.!octane carbamate derivatives and their use as muscarinic receptor antagonists
02/24/2005US20050043346 Pyridylpyrrole derivatives active as kinase inhibitors
02/24/2005US20050043337 Selective beta3 adrenergic agonists
02/24/2005US20050043332 Such as 4 (cis-3-hydroxycyclopentyl)amino-5,6-dimethyl-2-phenyl-7H-pyrrolo[2,3d] pyrimidine for treatment of adenosine receptor stimulated diseases, cardiovascular disorders, and nervous system disorders
02/24/2005US20050043326 Compounds
02/24/2005US20050043304 Lower alkyl molecular weight amine as enzyme inhibitors for use in the treatment of tryptase enzyme inhibitors inhibitorsfor respiratory system disorders, antiinflammatory agents, inflammatory bowel disease, hyperprolific skin disorders, vascular edema and rheumatoid arthritis
02/24/2005US20050043269 Pharmaceutically active uridine esters
02/24/2005US20050042738 Carbohydrate-associated proteins
02/24/2005US20050042731 Four helical bundle cytokine family polypeptide for use in treatment, diagnosis and prevention of infection, cardiovascular, metabolic, developmental, skin, bone, inflammatory and autoimmune disorders
02/24/2005US20050042667 Expression vector comprising nucleotide sequences coding polypeptide for use in diagnosis, treatment and prevention of immune, hematopoietic, inflammatory and tumor diseases
02/24/2005US20050042317 Complex mixtures exhibiting selective inhibition of cyclooxygenase-2
02/24/2005US20050042299 Use of milk serum apoproteins in the prophylaxis or treatment of microbial or viral infection
02/24/2005US20050042237 Method for administering a spill resistant pharmaceutical system
02/24/2005US20050042215 Combination treatments for allergic disease comprising administering an anti-ige antibody and antiallergic compound
02/24/2005US20050042202 Gentamicin, amikacin, tobramycin, netilmicin, cephalosporin, ceftazidine, maxalactam, carbopenem, imipenem, aztreonam, ampicillin, penicillin, ureidopenicillin, augmentin, amphotericin, famvir and/or acyclovir; and Vpr protein, fragment or nucleic acid encoding; systemic inflammatory response syndrome
02/24/2005US20050042175 Combined doses of formoterol and budesonide
02/24/2005US20050042174 Consistent inhalation dry powder metered doses; concurrent delivery of bronchodilator, anticholinergic agent and antiinflammatory steroid
02/24/2005US20050042173 Pharmaceuticals, cosmetics or nutraceuticals with a bioadhesive and plasticizer on a biodegradable support for transdermal or transmucosal application
02/24/2005US20050042172 Administration of medicaments by vaporisation
02/24/2005US20050042171 Only once daily administration of an antispasmodic beta-2 adrenergic agonist and an antiinflammatory corticosteroid; inhalation; salmeterol xinafoate
02/24/2005US20050039743 Medicament dispenser
02/24/2005CA2535620A1 6-substituted anilino purines as rtk inhibitors
02/24/2005CA2535416A1 Imidazopyridine derivatives
02/24/2005CA2530604A1 Combinatorial synthesis on support
02/23/2005EP1508330A1 Inhalation capsules
02/23/2005EP1507875A2 Assay for identifying inhibitors of fc gamma riii signaling
02/23/2005EP1507855A2 Elongase genes and uses thereof
02/23/2005EP1507780A1 Pyrazolo-pyrimidine aniline compounds useful as kinase inhibitors
02/23/2005EP1507779A1 Inhibitors of jak and cdk2 protein kinases
02/23/2005EP1507773A1 Macrocyclic compounds useful as pharmaceuticals
02/23/2005EP1507765A2 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor
02/23/2005EP1507760A1 Cyanoguanidine prodrugs
02/23/2005EP1507758A2 Indole derivatives and their use as ligands for cb2 receptors
02/23/2005EP1507754A1 Alkoxy aryl beta-2 adrenergic receptor agonists
02/23/2005EP1507555A2 Induction of antigen specific immunologic tolerance
1 ... 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 ... 878